Mirae Asset Global ETFs Holdings
VNDA icon

Mirae Asset Global ETFs Holdings’s Vanda Pharmaceuticals VNDA Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$223K Buy
32,504
+6,672
+26% +$51.5K ﹤0.01% 2305
2025
Q4 		$228K Sell
25,832
-306
-1% -$1.68K ﹤0.01% 2293
2025
Q3 		$130K Sell
26,138
-4,357
-14% -$20.2K ﹤0.01% 2547
2025
Q2 		$144K Sell
30,495
-3,570
-10% -$15.6K ﹤0.01% 2435
2025
Q1 		$156K Buy
34,065
+1,488
+5% +$6.94K ﹤0.01% 2435
2024
Q4 		$156K Buy
32,577
+1,395
+4% +$6.7K ﹤0.01% 2512
2024
Q3 		$146K Buy
31,182
+1,896
+6% +$10.2K ﹤0.01% 2529
2024
Q2 		$165K Buy
+29,286
New +$151K ﹤0.01% 2351

Other funds holding VNDA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return